Triple
T4850373
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Pfizer |
E108398
|
entity |
| Predicate | hasSubsidiary |
P254
|
FINISHED |
| Object |
G.D. Searle
G.D. Searle is a pharmaceutical company best known for developing the artificial sweetener aspartame and for its role in pioneering modern drug research before becoming part of larger industry conglomerates.
|
E476631
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: G.D. Searle | Statement: [Pfizer, hasSubsidiary, G.D. Searle]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: G.D. Searle Context triple: [Pfizer, hasSubsidiary, G.D. Searle]
-
A.
George Merck
George Merck was an American pharmaceutical executive best known for leading and expanding Merck & Co. into a major global drug company in the early 20th century.
-
B.
Fritz Hoffmann-La Roche
Fritz Hoffmann-La Roche was a Swiss entrepreneur and industrialist who founded the global healthcare and pharmaceutical company Roche in the late 19th century.
-
C.
Charles Pfizer
Charles Pfizer was a German-American chemist and entrepreneur who co-founded the pharmaceutical company Pfizer in the 19th century.
-
D.
B. B. Collip
B. B. Collip was a Canadian biochemist best known as a key member of the team that developed insulin as a treatment for diabetes.
-
E.
Henry Wellcome
Henry Wellcome was a British-American pharmaceutical entrepreneur and philanthropist whose fortune and vision led to the creation of one of the world’s largest biomedical research charities.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: G.D. Searle Triple: [Pfizer, hasSubsidiary, G.D. Searle]
Generated description
G.D. Searle is a pharmaceutical company best known for developing the artificial sweetener aspartame and for its role in pioneering modern drug research before becoming part of larger industry conglomerates.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: G.D. Searle Target entity description: G.D. Searle is a pharmaceutical company best known for developing the artificial sweetener aspartame and for its role in pioneering modern drug research before becoming part of larger industry conglomerates.
-
A.
George Merck
George Merck was an American pharmaceutical executive best known for leading and expanding Merck & Co. into a major global drug company in the early 20th century.
-
B.
Fritz Hoffmann-La Roche
Fritz Hoffmann-La Roche was a Swiss entrepreneur and industrialist who founded the global healthcare and pharmaceutical company Roche in the late 19th century.
-
C.
Charles Pfizer
Charles Pfizer was a German-American chemist and entrepreneur who co-founded the pharmaceutical company Pfizer in the 19th century.
-
D.
B. B. Collip
B. B. Collip was a Canadian biochemist best known as a key member of the team that developed insulin as a treatment for diabetes.
-
E.
Henry Wellcome
Henry Wellcome was a British-American pharmaceutical entrepreneur and philanthropist whose fortune and vision led to the creation of one of the world’s largest biomedical research charities.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69bd440a89548190a5f14ba6da6b97dc |
completed | March 20, 2026, 12:56 p.m. |
| NER | Named-entity recognition | batch_69bd6d1e5cf08190bd6b6a524748f170 |
completed | March 20, 2026, 3:51 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69be67da14d48190a994a11eb7a674b5 |
completed | March 21, 2026, 9:41 a.m. |
| NEDg | Description generation | batch_69be6864608c8190af22cc3ed949e1b9 |
completed | March 21, 2026, 9:44 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69be68e5b4e88190b7cd53d495f18a0f |
completed | March 21, 2026, 9:46 a.m. |
Created at: March 20, 2026, 1:25 p.m.